We are live on ! Find out more
CGT

Capital Guardian Trust Portfolio holdings

AUM $7.42B
1-Year Est. Return 26.1%
This Fund
S&P 500
This Quarter Est. Return
-11.78%
1 Year Est. Return
+26.1%
3 Year Est. Return
+126.33%
5 Year Est. Return
+154.65%
10 Year Est. Return
AUM
$6.28B
AUM Growth
-$1.13B
Cap. Flow
-$114M
Cap. Flow %
-1.81%
Top 10 Hldgs %
20.21%
Holding
517
New
12
Increased
64
Reduced
162
Closed
254

Top Buys

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$47.5M
2
ONC
BeOne Medicines Ltd
ONC
+$44.9M
3
EOG icon
EOG Resources
EOG
+$30M
4
NTAP icon
NetApp
NTAP
+$25.7M
5
LIN icon
Linde
LIN
+$25.6M

Top Sells

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$43M
2
INCY icon
Incyte
INCY
+$38.4M
3
BKNG icon
Booking.com
BKNG
+$35M
4
CME icon
CME Group
CME
+$25.7M
5
BTI icon
British American Tobacco
BTI
+$23.3M

Sector Composition

Rank Sector Weight
1 Technology 18.1%
2 Financials 17.09%
3 Healthcare 11.67%
4 Consumer Discretionary 11.2%
5 Industrials 10.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLF icon
476
State Street Financial Select Sector SPDR ETF
XLF
$58.4B
-4,317
Closed -$119K
XPO icon
477
XPO
XPO
$23B
-2,284
Closed -$90K
XRAY icon
478
Dentsply Sirona
XRAY
$2.64B
-831
Closed -$31K
YUMC icon
479
Yum China
YUMC
$16.5B
-3,025
Closed -$106K
ZTS icon
480
Zoetis
ZTS
$32.4B
-1,276
Closed -$117K
VRN
481
DELISTED
Veren
VRN
-5,900
Closed -$38K
INVX
482
Innovex International
INVX
$2.15B
-677
Closed -$35K
LSXMK
483
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
-604
Closed -$20K
LSXMA
484
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
-285
Closed -$9K
SPLK
485
DELISTED
Splunk Inc
SPLK
-83
Closed -$10K
SRC
486
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
-615
Closed -$25K
BKI
487
DELISTED
Black Knight, Inc. Common Stock
BKI
-914
Closed -$47K
ABB
488
DELISTED
ABB Ltd
ABB
-1,214
Closed -$29K
STOR
489
DELISTED
STORE Capital Corporation
STOR
-1,858
Closed -$52K
DRE
490
DELISTED
Duke Realty Corp.
DRE
-1,832
Closed -$52K
CDK
491
DELISTED
CDK Global, Inc.
CDK
-198
Closed -$12K
RVI
492
DELISTED
Retail Value Inc. Common Shares
RVI
-730
Closed -$2K
INFO
493
DELISTED
IHS Markit Ltd. Common Shares
INFO
-1,324
Closed -$71K
BPY
494
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
-196
Closed -$4K
ALXN
495
DELISTED
Alexion Pharmaceuticals
ALXN
-398
Closed -$55K
PRAH
496
DELISTED
PRA Health Sciences, Inc.
PRAH
-660
Closed -$73K
STAY
497
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
-818
Closed -$17K
HDS
498
DELISTED
HD Supply Holdings, Inc.
HDS
-97
Closed -$4K
GLIBA
499
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
-361
Closed -$18K
WBC
500
DELISTED
WABCO HOLDINGS INC.
WBC
-886
Closed -$104K

Similar funds

Capital Guardian Trust's Q4 2018 Portfolio in Review

As of Q4 2018, Capital Guardian Trust held 517 positions worth $6.28B, down 15% from $7.41B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Capital Guardian Trust's Q4 2018 filing shows 12 new, 64 increased, 162 reduced and 254 closed positions. Its largest new stake was Neurocrine Biosciences: 495,582 shares worth $35.4M. The largest sale was UBS Group, an estimated $43M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

  • Capital Guardian Trust's largest Q4 2018 buy was Neurocrine Biosciences: 495,582 shares worth $35.4M.
  • Capital Guardian Trust added most to EOG Resources in Q4 2018, an estimated $30M increase.
  • Capital Guardian Trust's biggest Q4 2018 reduction was UBS Group, cutting an estimated $43M.
  • Capital Guardian Trust fully exited PG&E in Q4 2018, selling an estimated $15.6M.
  • Capital Guardian Trust's ten largest holdings make up 20% of its $6.28B portfolio in Q4 2018.
  • Capital Guardian Trust opened 12 new positions and closed 254 in Q4 2018.
  • Capital Guardian Trust's portfolio value fell 15% quarter-over-quarter to $6.28B.

Based on Capital Guardian Trust's 13F filing for Q4 2018, filed 14 Feb 2019.